SAVE THE DATE: Eagle Pharmaceuticals to Host Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel
October 19 2022 - 3:39PM
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the
“Company”) today announced that the Company will host an Investor
Day on Tuesday, December 6, 2022, at the Lotte New York Palace
Hotel, at 8:00am ET.
The program will provide an opportunity for an in-depth look at
the Company’s hospital-based products, including CAL02, BARHEMSYS®
and BYFAVO®, and Enalare’s ENA-001. Featured speakers include Scott
Tarriff, President and Chief Executive Officer, senior members of
Eagle’s clinical and commercial teams, and noteworthy Key Opinion
Leaders, who will discuss the scientific rationale and potential
unmet medical needs for each pipeline asset and commercial
product.
Audience members will have the opportunity to ask questions
following the presentations.
Advance registration is required for this event. Institutional
investors and analysts are kindly requested to RSVP through this
link to attend.
A webcast of this event will be accessible via the Company’s
website at www.eagleus.com, under the Investors section.
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research
and development, clinical, manufacturing and commercial expertise.
Eagle is committed to developing innovative medicines that result
in meaningful improvements in patients’ lives. Eagle’s
commercialized products include vasopressin, PEMFEXY®, RYANODEX®,
BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS®
through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s
oncology and CNS/metabolic critical care pipeline includes product
candidates with the potential to address underserved therapeutic
areas across multiple disease states. Additional information is
available on Eagle’s website at www.eagleus.com.
Investor Relations for Eagle Pharmaceuticals,
Inc.: Lisa M. WilsonIn-Site Communications, Inc. T:
212-452-2793 E: lwilson@insitecony.com
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From May 2023 to May 2024